Clostridium diffi cile infection (CDI) in Galati county is an very important public health problem, the number of cases per 100 outpatients being in the fi rst 5, nationally. The percentage of community-associated infection in this county is higher than the national and european ones. We performed a prospective observational study on 720 patients admitted between 1. 01.2017-31.12.2018 in the Clinical Hospital of Infectious Diseases "St. Cuv. Parascheva" Galati and we analyzed comparative demographic data, risk factors, disease evolution and prognosis of a batch of 565 (78.47%) patients with healthcare facility associated infection, with a batch of 144 patients (20%) with community-associated infection. The identifi ed type of Clostridium diffi cile was ribotype 027 in 93.61% of the toxigenic strains studied. The study showed that CDI predominantly aff ects women in urban areas. Patients with community source are younger, with less comorbidities, have episodes of illness with lower severity and better prognosis both in terms of CDI recurrence and post-CDI death. Patients with a nosocomial source are older, with multiple comorbidities, with greater exposure to antibiotic, proton pump inhibitor and recent abdominal surgery, have severe episodes of the disease and have a poorer prognosis than those with a community source.
Introduction
Clostridium diffi cile infection has become an important public health issue following the outbreak of epidemics in Europe, Canada and United States (USA) in 2011. The emergence of these outbreaks, produced by a germ, initially known as normal intestinal commensal fl ora, of healthy newborns, was possible due to several genetic mutations that occurred in the historical strain, resulting in the emergence of strain BI / NAP1 / 027, a rapidly spreading strain, which produces an additional toxin (binary toxin), as well as an amount higher in toxins A and B, it has an increased capacity to generate spores and has 1 "Dunarea de Jos" University of Galati, Romania 2 Clinical Hospital of Infectious Diseases "St. Parascheva" Galati, Romania 3 "Ovidius" University of Constanta, Romania 4 Clinical Hospital of Infectious Diseases Constanta, Romania a higher resistance to fl uoroquinolones than the historical strain (1) (2) (3) (4) .
The 2011 outbreak study of the US epidemic reported: the estimated number of incidente cases of CDI is 453000, with 83000 recurrent, 29300 deaths within 30 days from CDI and a cost, attributed to CDI, for acute care hospitals of 3427 USD -9960 USD per episode, as well as a total annual cost of acute care, estimated at 1.2-5.9 billion USD. Also, it was found that 94% of the cases had a recent exposure to healthcare unit (5) (6) (7) (8) .
The most type of CD strain in the USA was ribotype 027 (28.4%), in a Centers for Disease Control and Prevention study in 2009 (9) , and in England, it had a prevalence of 55% in 2007 and 21% in 2010 (10) . This decrease in prevalence of this strain, in England, was associated with great decreases in CDI incidence and related mortality, and was attributed to decreased use of fluoroquinolones, increased awareness of CDI, and improved control of CDI. The Netherlands reported a virulent strain, ribotype 078 whose prevalence increased between 2005 and 2008 and was related with ribotype 027 as severity, but was associated with a population more younger and more CA-CDI (11) .
Some studies in Romania show that the main circulating CD is ribotype 027 (12, 13) . The number of cases per 100 outpatients in Galati county was in 2018, in the first 5, nationally Figure 1 (14, 15) . Figure 1 . The incidence of 100 discharged CDI cases reported by hospitals, in Romania, in 2018 (14) The source of the pathogen is the human and the wild or the domestic animals that host the Clostridium difficile (CD) in the gastrointestinal tract, (sick or healthy carriers). The transmission can be done in two ways. The direct mode is represented by transmitting the Clostridium difficile strain between the patients and between them and the medical personnel. The indirect mode is represented by the objects, including the clothing, the medical-sanitary equipment, the thermometers and the furniture, which constitute an important way of transmission. The hands can be contaminated directly (including by selfcontamination) or indirectly. Patients' receptivity to infections caused by Clostridium difficile occurs when the host-bacterial relationship is imbalanced. The body is susceptible to infection with these microorganisms when there are gaps in the commensal microflora of the colon (antibiotic, immunodepression) or mucosal barriers or the teguments are compromised by surgery, trauma, tumor, ischemia or necrosis, decreasing the potential for local oxide reduction. In addition, decreasing the body's overall resistance through age, alcoholism, diabetes, neoplasia, immunosuppression, angiopathy, results in increased responsiveness to CDI.
The infection with Clostridium difficile was initially considered nosocomial, afterwards there were cases in which an epidemiological link with any medical services unit could not be established and the community infection was studied.
Europe -A recent multicenter study in 34 European countries, of 97 hospitals applied increased surveillance criteria for CDI cases and found that 70/506 (14%) of cases were classified as community acquired (16) .
North America -A study, from 2010, in six North Carolina centers, reported a 20% prevalence of infections of community origin (CA-CDI) (17) . In another US multi-center study in eight geographical areas with 10,342 cases, the prevalence of CA-CDI was 32% (18). Allard and colleagues analized 15 hospitals in Montreal 2005-2006 and, 599/2297 (27%) cased were CA-CDI (19) .
Australia -A CDI study from three states, Tasmania, Western Australia and Victoria showed that CA-CDI accounted for 26% of all hospitalized CDI cases from 2010-2012 (20) .
The CDI incidence in Romania has been steadily increasing since 2011. The CDI surveillance system was implemented at the national level in March 2014, the target population being represented by all patients admitted to the state or private health units in the country. In Romania, in 2018, the number of 10241 cases confirmed, with 2% more cases than in 2017 (10080 cases) entered in the CDI surveillance system. Of the total 10,241 cases confirmed by the CDI, 7743 (76%) were classified as healthcare associated infections (HFA-CDI), 1931 (19%) CA-CDI and 567 (6%) infections of indeterminate origin (21).
The incidence of 100 outpatients of CDI cases reported by hospitals in Galati county in 2017 and 2018 was between 0.44 and 0.66, the maximum value at national level.
Materials and methods
A prospective observational study was conducted that evaluated the demographic and epidemiological characteristics of 720 patients hospitalized with the diagnosis of CDI at the Clinical Hospital of Infectious Diseases "St. Cuv. Parascheva" Galati, between 1.01.2017-31.12.2018.
The etiologic diagnosis for CD was done with coloured chromatographic immunoassay for the simultaneous qualitative detection of Clostridium diffi cile Glutamate Dehydrogenase (GDH), Toxin A and Toxin B. A subset of 50 patients benefi ted from a complex etiologic diagnosis that included real-time polymerase chain reaction (PCR) witch detects tcdB (CD toxin B encoding gene), cdt (binary toxin gene) and deletion of a nucleotide at position 117 of the tcdC gene, associated with ribotype 027 strain; and anaerobic culture in chromogenic media with Vitek identifi cation and bacilli visualization in optical or transmission electron microscopy.
Of these 720 patients, 565 (78.47%) of them were hospitalized prior to the onset of the disease in the last 0-4 weeks and were considered HFA-CDI, in 11 (1.52%) patients were hospitalized in the last 4-8 weeks and were considered infections of indefi nite origin and 144 (20%) patients either did not have continuous hospitalization during the last 8 weeks, or had them more than 8 weeks before the onset of the disease and were considered CA-CDI, Figure 2 .
Of these 720 patients, 565 (78.47%) of them were hospitalized prior to the onset of the disease in the last 0-4 weeks and were considered HFA-CDI, in 11 (1.52%) patients were hospitalized in the last 4-8 weeks and were considered infections of indefinite origin and 144 (20%) patients either did not have continuous hospitalization during the last 8 weeks, or had them more than 8 weeks before the onset of the disease and were considered CA-CDI, Figure   2 . 
Results
The three groups of patients: the total group, the HFA-CDI group and the CA-CDI group were analyzed compared to the Medcalc statistical analysis program and the results were summarized in Table I,II . 
The three groups of patients: the total group, the HFA-CDI group and the CA-CDI group were analyzed compared to the Medcalc statistical analysis program and the results were summarized in Table 1 ,2.
In all groups, the female gender and the urban environment predominated, the most signifi cant share being in the CA-CDI group.
In the HFA-CDI group we analyzed the percentage of the hospitals and the source sections, in which the patients had a hospitalization beetween 0-4 weeks before the onset of CDI. The hospitals with the most source cases were the Emergency County Clinical Hospital "St. Andrei" from Galati -68.84%, the Clinical Hospital of Infectious Diseases "St. Parascheva" Galati -8.67%, the Pneumophysiology Hospital Galati -8.31%, Figure 4 . diseases -8.49%, pneumology -6.52% gastroenterology -6.38%, Figure 5 . 
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Figure 5. The main source departments for CDI
A batch of 50 patients who had postitive chromatographic immunoassay for GDH and at least one toxin A or B, also did a PCR test to determine the ribotype of the strain (027 or not).
The results were: 48 valid tests (2 errors) of which one test with non-toxygen strain, 3 tests with toxigenic strains other than 027, 44 tests with 027 ribotype (93.61% of the toxigenic strains).
Interpretation of the CDI risk factors
The average age in the total group and in the HFA-CDI group was over 65 years, considered a risk factor for CDI and falling in the first category of severity of the episode of the disease quantified by the Atlas score, the patients in the HFA-CDI group being those older. The patients in the CA-CDI group were the youngest, with the average age below the risk threshold for CDI, with the median at the beginning of the first category of severity of the episode of the disease quantified by the Atlas score (60 years). Patients with CDI associate with multiple comorbidities, most often being the cause of the risk factors for CDI, either by consecutive immunosuppression or by nosocomial contact, or by the need for antibiotic or proton pump inhibitors (PPI). We appreciated the cumulative comorbidities of our patients through the Charlson score (22) .
In the HFA-CDI group, the highest values of this score were registered, 24.77% of patients with a survival expectancy of 2-21% at 10 years and 29.73% with a survival expectancy at 10 years equal to 0. The CA-CDI patients group presented a much smaller cumulative score, 20% 15.04% 8.49%
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The main source departments for CDI
A batch of 50 patients who had postitive chromatographic immunoassay for GDH and at least one toxin A or B, also did a PCR test to determine the ribotype of the strain (027 or not). The results were: 48 valid tests (2 errors) of which one test with non-toxygen strain, 3 tests with toxigenic strains other than 027, 44 tests with 027 ribotype (93.61% of the toxigenic strains).
Interpretation of the CDI risk factors
The average age in the total group and in the HFA-CDI group was over 65 years, considered a risk factor for CDI and falling in the fi rst category of severity of the episode of the disease quantifi ed by the Atlas score, the patients in the HFA-CDI group being those older. The patients in the CA-CDI group were the youngest, with the average age below the risk threshold for CDI, with the median at the beginning of the fi rst category of severity of the episode of the disease quantifi ed by the Atlas score (60 years). Patients with CDI associate with multiple comorbidities, most often being the cause of the risk factors for CDI, either by consecutive immunosuppression or by nosocomial contact, or by the need for antibiotic or proton pump inhibitors (PPI). We appreciated the cumulative comorbidities of our patients through the Charlson score (22) .
In the HFA-CDI group, the highest values of this score were registered, 24.77% of patients with a survival expectancy of 2-21% at 10 years and 29.73% with a survival expectancy at 10 years equal to 0. The CA-CDI patients group presented a much smaller cumulative score, with 77.77% of patients with 10-year survival expectancy over 50%. Antibiotic use in the last 8 weeks prior to the onset of CDI was statistically signifi cantly higher in the HFA-CDI group. In this group aminopenicillins were given in 4.77% of patients receiving antibiotics, cephalosporins in 32.62%, fl uoroquinolones in 22.81%, carbapenems in 1.59%, clindamycin in 0.53%. In the community group aminopenicillins were given in 21.31% of patients receiving antibiotics, cephalosporins in 31.14%, fl uoroquinolones in 22.95%, carbapenems in 1.63%. With the exception of aminopenicillins, which have a higher percentage in the CA-CDI group, the other antibiotics were used in similar way in the two groups, which leads to the idea of the necessity of revising the protocols for the administration of cephalosporins and fl uoroquinolones both in the ambulatory and in the hospital. Recent abdominal surgery and PPI use were statistically signifi cantly higher in the HFA-CDI group.
Interpretation of the severity of the episode of CDI
The ATLAS score (23) was commonly used to assess the severity of CDI for choosing specifi c antibiotic treatment has recently been correlated, in some studies, with the risk of death by CDI (24) and in the HFA-CDI group has statistically signifi cantly higher severity scores than in the CA-CDI group. The duration of the hospitalization was slightly higher in the group with HFA-CDI, and the duration of the specifi c antibiotic treatment summing both the period of hospitalization and the prescription at home was similar in the three groups studied.
CDI recurrences, defi ned as new episodes of disease occurring in the range 0-8 weeks after a CDI episode with a clinical resolution, are statistically signifi cantly more in the HFA-CDI group than in the CA-CDI group.
Reinfections with CD, defi ned as new episodes of disease occurring over 8 weeks after an episode of CDI with clinical resolution, are similar in the three groups studied.
The deaths occurring during the hospitalization for CDI and within 30 days from the discharge for CDI, are significantly statistically more in the HFA-CDI group than in the CA-CDI group.
Discussions
In Romania, the percentage of CA-CDI cases is higher than the european one. Galati County is, in 2018, in the top 5 counties with the highest number of CDI cases at 100 discharges. In the south-east region, Galati county has the highest number of CDI cases. The study presented is performed on about half of the cases of the county and shows a higher percentage of CA-CDI cases than the national one.
The CA-CDI group included younger patients with fewer comorbidities who developed episodes of disease with lower severity and with a better prognosis in both CDI recurrence and post-CDI death than those with nosocomial source.
The HFA-CDI group included older patients with multiple comorbidities, with higher exposure to antibiotic use, PPI and recent abdominal surgery, who developed more severe episodes of the disease with a poorer prognosis than those with community source.
Conclusions
The main source of CDI is nosocomial, associated with the intensive and / or inadequate use of antibiotics, but we observed the spread of infection in the community. The increase in the number of community cases, especially in young people, can be correlated with the easy access to the use of antibiotics and proton pump inhibitors, even without a prescription.
Prolonged hospitalization, antibiotic theraphy errors and inadequate hygiene are associated with the onset of nosocomial CDI.
Promoting the rules for preventing the transmission of CDI and "antibiotic stewardship" strategies are the key to limiting CDI.
